Retraction notice (The Journal of Allergy and Clinical Immunology (2015) 135(4) (930–935.e1), (S009167491401793X), (10.1016/j.jaci.2014.12.013));Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year

Journal of Allergy and Clinical Immunology

Volumn 135, Issue 4, 2015, Pages 930-935.e1

  Kelleher, Maeve ^a   Dunn Galvin, Audrey ^a   Hourihane, Jonathan O'B ^a,b   Murray, Deirdre ^a,b   Campbell, Linda E ^c   McLean, W H Irwin ^c   Irvine, Alan D ^b,d,e  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b NATIONAL CHILDREN S RESEARCH CENTRE   (Ireland)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^e TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

atopic dermatitis; biomarker; filaggrin; Infant; predictor; skin barrier; TEWL

Indexed keywords

FILAGGRIN; INTERMEDIATE FILAMENT PROTEIN;

ARTICLE; ATOPIC DERMATITIS; BIRTH WEIGHT; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; INFANT; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NEWBORN; NOTTINGHAM SEVERITY SCORE; PREDICTIVE VALUE; PRIORITY JOURNAL; SCORING ATOPIC DERMATITIS CLINICAL TOOL; SCORING SYSTEM; SKIN BARRIER FUNCTION; SKIN FUNCTION; SKIN WATER LOSS; UMBILICAL CORD BLOOD; DERMATITIS, ATOPIC; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROGNOSIS; RISK; SKIN; TIME;

DERMATITIS, ATOPIC; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; INTERMEDIATE FILAMENT PROTEINS; MALE; PROGNOSIS; RISK; SKIN; TIME FACTORS;

EID: 84926254458     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2021.02.002     Document Type: Erratum

References (36)

1. S.G. Johansson, T. Bieber, R. Dahl, P.S. Friedmann, B.Q. Lanier, and R.F. Lockey Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003 J Allergy Clin Immunol 113 2004 832 836
2. E.M. Duggan, J. Sturley, A.P. Fitzgerald, I.J. Perry, and J.O. Hourihane The 2002-2007 trends of prevalence of asthma, allergic rhinitis and eczema in Irish schoolchildren Pediatr Allergy Immunol 23 2012 464 471
3. N. Aberg, B. Hesselmar, B. Aberg, and B. Eriksson Increase of asthma, allergic rhinitis and eczema in Swedish schoolchildren between 1979 and 1991 Clin Exp Allergy 25 1995 815 819
4. J.K. Peat, R.H.V.D. Berg, W.F. Green, C.M. Mellis, S.R. Leeder, and A.J. Wolcock Changing prevalence of asthma in Australian children BMJ 308 1994 1591 1596
5. J. Grundy, S. Matthews, B. Bateman, T. Dean, and S.H. Arshad Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts J Allergy Clin Immunol 110 2002 784 789
6. J.M. Spergel Epidemiology of atopic dermatitis and atopic march in children Immunol Allergy Clin North Am 30 2010 269 280
7. S. Illi, E. von Mutius, S. Lau, R. Nickel, C. Grüber, and B. Niggemann The natural course of atopic dermatitis from birth to age 7 years and the association with asthma J Allergy Clin Immunol 113 2004 925 931
8. M.R. Sears, M.D. Holdway, E.M. Flannery, G.P. Herbison, and P.A. Silva Parental and neonatal risk factors for atopy, airway hyper-responsiveness, and asthma Arch Dis Child 75 1996 392 398
9. M.A. Portelli, E. Hodge, and I. Sayers Genetic risk factors for the development of allergic disease identified by genome-wide association Clin Exp Allergy 45 2015 21 31
10. C.N. Palmer, A.D. Irvine, A. Terron-Kwiatkowski, Y. Zhao, H. Liao, and S.P. Lee Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis Nat Genet 38 2006 441 446
11. A. Sandilands, C. Sutherland, A.D. Irvine, and W.H. McLean Filaggrin in the frontline: role in skin barrier function and disease J Cell Sci 122 2009 1285 1294
12. M.A. McAleer, and A.D. Irvine The multifunctional role of filaggrin in allergic skin disease J Allergy Clin Immunol 131 2013 280 291
13. A.D. Irvine, W.H. McLean, and D.Y. Leung Filaggrin mutations associated with skin and allergic diseases N Engl J Med 365 2011 1315 1327
14. E. Rodríguez, H. Baurecht, E. Herberich, S. Wagenpfeil, S.J. Brown, and H.J. Cordell Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease J Allergy Clin Immunol 123 2009 1361 1370.e7
15. S.J. Brown, and W.H. McLean One remarkable molecule: filaggrin J Investig Dermatol 132 2012 751 762
16. J. Nikolovski, G.N. Stamatas, N. Kollias, and B.C. Wiegand Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life J Investig Dermatol 128 2008 1728 1736
17. M.J. Cork, S.G. Danby, Y. Vasilopoulos, J. Hadgraft, M.E. Lane, and M. Moustafa Epidermal barrier dysfunction in atopic dermatitis J Invest Dermatol 129 2009 1892 1908
18. S. Seidenari, and G. Giusti Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin Acta Derm Venereol 75 1995 429 433
19. C. Flohr, K. England, S. Radulovic, W.H. McLean, L.E. Campbell, and J. Barker Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age Br J Dermatol 163 2010 1333 1336
20. P.M. Elias, Y. Hatano, and M.L. Williams Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms J Allergy Clin Immunol 121 2008 1337 1343
21. J. Strid, J. Hourihane, I. Kimber, R. Callard, and S. Strobel Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response Eur J Immunol 34 2004 2100 2109
22. G. Lack, D. Fox, K. Northstone, and J. Golding Factors associated with the development of peanut allergy in childhood N Engl J Med 348 2003 977 985
23. F. Boralevi, T. Hubiche, C. Leaute-Labreze, E. Saubusse, M. Fayon, and S. Roul Epicutaneous aeroallergen sensitization in atopic dermatitis infants-determining the role of epidermal barrier impairment Allergy 63 2008 205 210
24. E.L. Simpson, T.M. Berry, P.A. Brown, and J.M. Hanifin A pilot study of emollient therapy for the primary prevention of atopic dermatitis J Am Acad Dermatol 63 2010 587 593
25. E.L. Simpson, J.R. Chalmers, J.M. Hanifin, K.S. Thomas, M.J. Cork, and W.H. McLean Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention J Allergy Clin Immunol 134 2014 818 823
26. K. Horimukai, K. Morita, M. Narita, M. Kondo, H. Kitazawa, and M. Nozaki Application of moisturizer to neonates prevents development of atopic dermatitis J Allergy Clin Immunol 134 2014 824 830.e6
27. AB. MSN. Welcome to the BASELINE study. 2008. Available at: http://www.baselinestudy.net/. Accessed June 26, 2013.
28. SCOPE Consortium and MedSciNet AB. 2004. Available at: http://www.scopestudy.net/. Accessed May 9, 2013.
29. H.C. Williams, P.G. Jburney, A.C. Pembroke, and R.J. Hay The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis, III: independent hospital validation Br J Dermatol 131 1994 406 416
30. H.C. Williams, P.G. Burney, R.J. Hay, C.B. Archer, M.J. Shipley, and J.J. Hunter The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis, I: derivation of a minimum set of discriminators for atopic dermatitis Br J Dermatol 131 1994 383 396
31. H.C. Williams, P.G. Burney, D. Strachan, and R.J. Hay The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis, II: observer variation of clinical diagnosis and signs of atopic dermatitis Br J Dermatol 131 1994 397 405
32. J.F. Stalder, and A. Taïeb Severity scoring of atopic dermatitis: the SCORAD index Dermatology 186 1993 23 31
33. B. Kunz, A.P. Oranje, L. Labrèze, J.F. Stalder, J. Ring, and A. Taïeb Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis Dermatology 195 1997 10 19
34. R.M. Emerson, C.R. Charman, and H.C. Williams The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading Br J Dermatol 142 2000 288 297
35. G. Maldonado, and S. Greenland Simulation study of confounder-selection strategies Am J Epidemiol 138 1993 923 936
36. E. Budtz-Jørgensen, N. Keiding, P. Grandjean, and P. Weihe Confounder selection in environmental epidemiology: assessment of health effects of prenatal mercury exposure Ann Epidemiol 17 2007 27 35